Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Sep 1;20(121):132-3.
doi: 10.1183/09059180.00001511.

Idiopathic pulmonary fibrosis: present understanding and future options

R M du Bois
Editorial

Idiopathic pulmonary fibrosis: present understanding and future options

R M du Bois. Eur Respir Rev. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Statement of Interest

R.M. du Bois has received reimbursement for attending the symposium, and fees for speaking and consultancy.

Figures

Figure 1.
Figure 1.
Mortality rates for pulmonary fibrosis significantly increased in the USA between 1992 and 2003 [1]. ▪: males; •: females.
Figure 2.
Figure 2.
The number of patients enrolled in clinical studies of idiopathic pulmonary fibrosis (IPF) has increased substantially in the past decade compared to the previous decade [–16]. Figure provided courtesy of L. Richeldi (University Modena and Reggio Emilia, Modena, Italy; personal communication).
See this image and copyright information in PMC

References

    1. Olson AL, Swigris JJ, Lezotte DC, et al. . Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 2007; 176: 277–284. - PubMed
    1. Altekruse S F, Kosary C L, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975–2007. Bethesda: National Cancer Institute; 2011. http://seer.cancer.gov/csr/1975_2007
    1. Raghu G, Depaso WJ, Cain K, et al. . Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991; 144: 291–296. - PubMed
    1. Douglas WW, Ryu JH, Swensen SJ, et al. . Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group. Am J Respir Crit Care Med 1998; 158: 220–225. - PubMed
    1. Ziesche R, Hofbauer E, Wittmann K, et al. . A preliminary study of long-term treatment with interferon γ-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999; 341: 1264–1269. - PubMed

Publication types

MeSH terms

LinkOut - more resources